Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The lancets market stood at a value of around USD 1061 million in 2022. The lancets market is further projected to expand to reach USD 1742 million by 2028., growing at a CAGR of 9% during the forecast period of 2023-2028.
The growth of the lancets market can be ascribed to the availability of a big pool of diabetic patients and the growing incidences of infectious diseases requiring blood testing for diagnosis and therapy, along with increased awareness of diabetes treatment globally.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Lancet, a fine, sharply pointed needle, is a small medical implement used to prick the skin, particularly for blood sugar monitoring or capillary blood sampling. The global lancets market can be divided based on segments like types, end-uses, and applications.
The lancets market, on the basis of lancet-type, can be divided into safety lancets and personal lancets. Safety lancet is further subdivided into push-button lancets and pressure-activated lancets. The industry can be divided on the basis of its application into glucose testing, haemoglobin testing, and coagulation testing, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The lancets market can be broadly categorised based on its end use into:
The EMR report looks into the regional lancets markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growth in the lancets market is primarily driven by the increasing incidences of diabetes and high infectious diseases worldwide. Emerging markets such as India and China are anticipated to provide growth possibilities during the forecast period for the players in the lancets market. However, the danger of needlestick injuries, the reuse of lancets, and the bad reimbursement situation may act as the major market constraints, hampering the lancets market growth.
The hospitals and clinics segment is anticipated to lead the global lancets industry in 2021. While it is expected that North America will dominate the lancets market in 2021, the Asia Pacific region is projected to witness the highest CAGR over the forecast period. The increasing healthcare sector, increasing geriatric population in China and India, fast financial development, and increased awareness of diabetes treatment are some of the primary factors, which are aiding in the growth of the Asia Pacific lancets market.
The report presents a detailed analysis of the following key players in the global lancets market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the lancets market by providing a SWOT analysis as well as an assessment of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, End Use, Region |
Breakup by Type | Safety Lancets, Personal Lancets |
Breakup by Application | Glucose Testing, Haemoglobin Testing, Coagulation Testing, Other Applications |
Breakup by End Use | Hospitals & Clinics, Home Care Settings, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | F. Hoffmann-La Roche Ltd., Owen Mumford Limited, Arkray Inc., Medline Industries Inc., Sterilance Medical (Suzhou) Inc., Becton, Dickinson and Company (NYSE: BDX), Ypsomed AG (SWX: YPSN), B. Braun Melsungen AG, Terumo Medical Corporation, HTL-Strefa S.A, Sarstedt AG and Co. KG, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Lancets Market Analysis
8.1 Key Industry Highlights
8.2 Global Lancets Historical Market (2018-2022)
8.3 Global Lancets Market Forecast (2023-2028)
8.4 Global Lancets Market by Type
8.4.1 Safety Lancets
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.1.4 Safety Lancets by Type
8.4.1.4.1 Push-Button Lancets
8.4.1.4.2 Pressure-Activated Lancets
8.4.2 Personal Lancets
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Lancets Market by Application
8.5.1 Glucose Testing
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Hemoglobin Testing
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Coagulation Testing
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Other Applications
8.6 Global Lancets Market by End Use
8.6.1 Hospitals and Clinics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Home Care Settings
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Lancets Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Price Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 F. Hoffmann-La Roche Ltd. (SWX: ROG)
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Owen Mumford Limited
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Arkray Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Medline Industries Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Sterilance Medical (Suzhou) Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Becton, Dickinson and Company
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Ypsomed AG
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 B. Braun Melsungen AG
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 Terumo Medical Corporation
12.2.9.1 Company Overview
12.2.9.2 Product Portfolio
12.2.9.3 Demographic Reach and Achievements
12.2.9.4 Certifications
12.2.10 HTL-Strefa S.A.
12.2.10.1 Company Overview
12.2.10.2 Product Portfolio
12.2.10.3 Demographic Reach and Achievements
12.2.10.4 Certifications
12.2.11 SARSTEDT AG & Co. KG
12.2.12.1 Company Overview
12.2.12.2 Product Portfolio
12.2.12.3 Demographic Reach and Achievements
12.2.12.4 Certifications
12.2.12 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Lancets Market: Key Industry Highlights, 2018 and 2028
2. Global Lancets Historical Market: Breakup by Type (USD Million), 2018-2022
3. Global Lancets Market Forecast: Breakup by Type (USD Million), 2023-2028
4. Global Lancets Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Lancets Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Lancets Historical Market: Breakup by End Use (USD Million), 2018-2022
7. Global Lancets Market Forecast: Breakup by End Use (USD Million), 2023-2028
8. Global Lancets Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Lancets Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Lancets Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Lancets Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Lancets Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Lancets Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Lancets Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Lancets Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Lancets Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Lancets Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Lancets Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Lancets Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Lancets Market Structure
In 2020, the global lancets market attained a value of nearly USD 1061 million.
The market is projected to grow at a CAGR of 9% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach about USD 1742 million by 2028.
The major drivers of the industry include rising disposable incomes, availability of a big pool of diabetic patients, growing incidences of infectious diseases requiring blood testing for diagnosis and therapy, increased awareness of diabetes treatment, rising demand from the developing regions, increasing geriatric population, and the growing technological advancements.
The key market trend guiding the growth of the lancets industry include the advancements in the technology.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Safety and personal lancets are the major types of lancets in the industry.
Glucose testing, haemoglobin testing, and coagulation testing, among others are the major application segments of the product in the industry.
Hospitals and clinics and home care settings among others are the significant end-uses of lancets in the industry.
The major players in the industry are F. Hoffmann-La Roche Ltd., Owen Mumford Limited, Arkray Inc., Medline Industries Inc., Sterilance Medical (Suzhou) Inc., Becton, Dickinson and Company (NYSE: BDX), Ypsomed AG (SWX: YPSN), B. Braun Melsungen AG, Terumo Medical Corporation, HTL-Strefa S.A, Sarstedt AG and Co. KG, Others.
The global lancets market attained a value of USD 1061 million in 2022, driven by the rising availability of a big pool of diabetic patients and the growing incidences of infectious diseases requiring blood testing for diagnosis and therapy. Aided by the technological advancements, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 9%. The lancets market is projected to reach USD 1742 million by 2028.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the industry can be segmented into safety and personal lancets. On the basis of application segments, the industry is divided into glucose testing, haemoglobin testing, and coagulation testing, among others. On the basis of end uses, the industry is categorised into hospitals and clinics and home care settings among others. The major regional markets for lancets are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd., Owen Mumford Limited, Arkray Inc., Medline Industries Inc., Sterilance Medical (Suzhou) Inc., Becton, Dickinson and Company (NYSE: BDX), Ypsomed AG (SWX: YPSN), B. Braun Melsungen AG, Terumo Medical Corporation, HTL-Strefa S.A, Sarstedt AG and Co. KG, Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.